Bhaskar Anand - 21 Oct 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role: Chief Accounting Officer
Signature: /s/ Bhaskar Anand
Issuer symbol: SMMT
Transactions as of: 21 Oct 2025
Net transactions value: +$499,983
Form type: 4
Filing time: 23 Oct 2025, 16:11:53 UTC
Previous filing: 19 Sep 2025
Next filing: 12 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Anand Bhaskar	Chief Accounting Officer	C/O SUMMIT THERAPEUTICS INC., 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI	/s/ Bhaskar Anand	23 Oct 2025	0001890784

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SMMT	Common Stock	Award	$499,983	+26,680	+20%	$18.74	159,751	21 Oct 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.
F2	Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.